JMI LABS IS NOW PART OF LEARN MORE

Comparative activity of gatifloxacin against S. pneumoniae, H. influenzae, and M. catarrhalis before (1997-99) and during (2000) the clinical release in North America (NA): A SENTRY Antimicrobial Surveillance Program Report, abstr P7. by Jones RN, Pfaller MA, and the SENTRY Participants Group. published in J. Antimicrob. Chemother. 2001; 47 (Suppl S2): 18